Two major drug wholesalers recently agreed to pay millions of dollars to settle claims they failed to report suspicious orders for opioid painkillers to the Drug Enforcement Administration, according to NPR.
Officials in Massachusetts report a cluster of 14 patients who experienced sudden-onset amnesia, which they suspect was caused by opioids. Thirteen of the patients reported current or past substance abuse, and 12 said they used opioids.
Thirteen drug distribution companies knew or should have known that hundreds of millions of prescription narcotic pills were ending up on the black market, according to an investigation by The Washington Post.
A new study finds the risk of prescription opioid addiction rose 37 percent among young adults between 2002 and 2014. Past-year heroin use also rose among 18- to 25-year-olds, from 2 percent to 7 percent.
Drug manufacturers and nonprofits funded by those companies resisted efforts by Washington state to place limits on prescriptions for opioid painkillers, according to the Associated Press and Center for Public Integrity.
Most patients taking opioid painkillers are willing to fill a prescription for the opioid overdose antidote naloxone, a new small study suggests. Prescribing naloxone to patients taking opioid painkillers is increasingly recommended by medical guidelines, HealthDay reports.
An advisory panel to the Food and Drug Administration has recommended approving a long-acting opioid painkiller that the manufacturer says could deter abuse. The company that makes the new drug, Arymo ER, says it comes in a tablet that is extremely hard, making it more difficult to break down.
A new study finds a non-drug approach to pain management that combines behavioral therapy and social support is effective. The researchers say such an approach could help reduce addiction to opioid painkillers, Science Daily reports.
State drug prescription monitoring programs help prevent 10 opioid-overdose deaths daily in the United States, a new study finds. Improvements in the programs could save another two people daily, the researchers said.
Pfizer, the world’s second-largest drug maker, has agreed to adhere to strict standards for marketing and promoting prescription opioids to treat common chronic pain conditions, such as arthritis and back pain.
Some doctors are voicing their opposition to new state laws that limit opioid prescribing. The American Medical Association and other medical groups say doctors and patients should be able to balance the need to treat pain against the risk of addiction, Stateline reports.